Explanipedia

Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial Open

Rosaria Talarico, Nazzareno Italiano, Giacomo Emmi, Matteo Piga, Luca Cantarini , et al. · 2024

The overall results of this study confirm the effectiveness of both IFX and ADA in achieving remission in patients with BS affected by mucocutaneous involvement.

Baricitinib and Pulse Steroids Combination Treatment in Hyperinflammatory COVID-19: A Rheumatological Approach in the Intensive Care Unit Open

Francesco Ferro, Gaetano La Rocca, Elena Elefante, Nazzareno Italiano, Michele Moretti , et al. · 2024

Hyperinflammatory Coronavirus disease 2019 (COVID-19) and rapidly-progressive interstitial lung diseases (RP-ILD) secondary to inflammatory myopathies (IIM) present important similarities. These data support the use of anti-rheumatic drugs…

Systemic vasculitis: one year in review 2024 Open

Elena Treppo, Sara Monti, Paolo Delvino, Chiara Marvisi, Caterina Ricordi , et al. · 2024

Systemic vasculitides comprise a collection of rare and heterogeneous disorders capable of impacting any organ and system, posing a considerable burden of mortality and comorbidity. As with previous annual reviews of this series, this revi…

AB0719 IS AORTIC 18FDG-UPTAKE PREVALENCE UNDERESTIMATED? DATA FROM A LARGE HOSPITAL-BASED COHORT Open

Nazzareno Italiano, F. Di Cianni, P. A. Erba, Rosaria Talarico, Marta Mosca · 2023

AB0773 IMPROVING ADHERENCE TO TREATMENT IN BEHÇET’S DISEASE - THE MULTI-STAKEHOLDER IMPACT_BD INTERNATIONAL STUDY Open

Diana Marinello, Ergin Çam, Federica Di Cianni, Laura Forrest, Farida Fortune , et al. · 2023

Background Behçet's disease (BD) is a rare, and severe, multisystemic inflammatory disease characterized by recurrent oral aphthous ulcers, genital ulcers, skin lesions, and both anterior and posterior uveitis; articular, vascular, gastroe…

Systemic vasculitis: one year in review 2023 Open

Michele Moretti, Elena Treppo, Sara Monti, Gaetano La Rocca, Giulia Del Frate , et al. · 2023

Systemic vasculitides are heterogeneous disabling diseases characterised by chronic inflammation of the blood vessels potentially leading to tissue destruction and organ failure. The recent COVID-19 pandemic has had a significant impact on…

Sleep quality in Behçet’s disease: a systematic literature review Open

Nazzareno Italiano, Federica Di Cianni, Diana Marinello, Elena Elefante, Marta Mosca , et al. · 2022

AB0588 GIANT CELL ARTERITIS: DO DIFFERENT PHENOTYPES OF PRESENTATION MEAN DIFFERENT CLINICAL ENTITIES? Open

Nazzareno Italiano, F. Di Cianni, E. Elefante, F. Ferro, P. A. Erba , et al. · 2022

COVID-19 mRNA vaccine booster in patients with autoimmune rheumatic diseases Open

Chiara Cardelli, Teresita Caruso, Chiara Tani, Federico Pratesi, Rosaria Talarico , et al. · 2022

Systemic vasculitis: one year in review 2022 Open

Gaetano La Rocca, Giulia Del Frate, Paolo Delvino, Federica Di Cianni, Michele Moretti , et al. · 2022

Systemic vasculitis are rare heterogeneous disorders potentially involving any organ and system with a relevant burden of mortality and comorbidity.As in the previous annual reviews of this series, in this review we will provide a critical…

Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodies Open

Chiara Tani, Federico Pratesi, Rosaria Talarico, Chiara Cardelli, Teresita Caruso , et al. · 2021

Objectives In patients with systemic autoimmune rheumatic disorders (SARDs), vaccination with SARS-CoV-2 mRNA vaccines has been proposed. The aim of this study is to evaluate the immune response elicited by vaccination with mRNA vaccine, t…

Nazzareno Italiano YOU? Author Swipe